Medically reviewed by Casey Gallagher, MD Finding an effective treatment for psoriatic disease (PD) often requires trial and ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

There are dozens of medications available ... of inflammatory arthritis such as psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis, biologic response modifiers (biologics ...

A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have cardiovascular ...

Rheumatoid arthritis (RA ... Special discount programmes are available for each of the biologic DMARDs, but the high cost of these drugs limits access in the United States and elsewhere.

Psoriatic arthritis (PsA ... to hold artificial teeth called crowns. Biologics for PsA treatment may cause problems with dental implant surgery. These drugs target specific cells and proteins ...

The rise in Biocon stock was also fuelled after Jefferies upgraded the stock to 'Buy', and raised the target to Rs 400 ...

Biocon Biologics had entered into a settlement and licensing agreement with Janssen Biotech Inc. and Janssen Sciences Ireland ...

Experts propose potential workarounds for obstacles to wider use of combined clinics and personalized medicine for ...